LncRNA-TUG1 Promotes Cell Growth and Chemo-Resistance by Regulating CCND2 via Epigenetically Silencing of miR-194-5p in Bladder Cancer

Molecular Therapy - Nucleic Acids - United States
doi 10.1016/j.omtn.2019.02.017
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Long Non-Coding RNA TUG1 Promotes Cell Progression in Hepatocellular Carcinoma via Regulating miR-216b-5p/DLX2 Axis

Cancer Cell International
Cancer ResearchOncologyGenetics
2020English

Long Non-Coding RNA TUG1 Promotes Cervical Cancer Progression by Regulating the miR-138-5p-SIRT1 Axis

Oncotarget
Oncology
2017English

LncRNA CCAT1 Promotes Prostate Cancer Cell Proliferation by Interacting With DDX5 and miR-28-5p

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

LncRNA LINC00460 Promotes the Papillary Thyroid Cancer Progression by Regulating the LINC00460/miR-485-5p/Raf1 Axis

Biological Research
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgricultural
2019English

LncRNA UCA1 Promotes Renal Cell Carcinoma Proliferation Through Epigenetically Repressing P21 Expression and Negatively Regulating miR-495

Tumor Biology
MedicineCancer Research
2017English

LncRNA GACAT1 Promotes Gastric Cancer Cell Growth, Invasion and Migration by Regulating MiR-149-mediated of ZBTB2 and SP1

Journal of Cancer
Oncology
2018English

The lncRNA LINC01194/miR-486-5p Axis Facilitates Malignancy in Non-Small Cell Lung Cancer via Regulating CDK4

OncoTargets and Therapy
OncologyPharmacology
2020English

LncRNA UCA1 Promotes the Invasion and EMT of Bladder Cancer Cells by Regulating the miR‑143/HMGB1 Pathway

Oncology Letters
Cancer ResearchOncology
2017English

DUXAP8, a Pseudogene Derived lncRNA, Promotes Growth of Pancreatic Carcinoma Cells by Epigenetically Silencing CDKN1A and KLF2

Cancer Communications
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy